|
1
|
Devine K, Mumford SL, Wu M, DeCherney AH,
Hill MJ and Propst A: Diminished ovarian reserve in the United
States assisted reproductive technology population: Diagnostic
trends among 181,536 cycles from the Society for assisted
reproductive technology clinic outcomes reporting system. Fertil
Steril. 104:612–619.e3. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Greene AD, Patounakis G and Segars JH:
Genetic associations with diminished ovarian reserve: A systematic
review of the literature. J Assist Reprod Genet. 31:935–946.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhao M, Feng F, Chu C, Yue W and Li L: A
novel EIF4ENIF1 mutation associated with a diminished ovarian
reserve and premature ovarian insufficiency identified by
whole-exome sequencing. J Ovarian Res. 12(119)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gleicher N, Kim A, Weghofer A, Kushnir VA,
Shohat-Tal A, Lazzaroni E, Lee HJ and Barad DH: Hypoandrogenism in
association with diminished functional ovarian reserve. Hum Reprod.
28:1084–1091. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Vodo S, Bechi N, Petroni A, Muscoli C and
Aloisi AM: Testosterone-induced effects on lipids and inflammation.
Mediators Inflamm. 2013(183041)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sen A, Prizant H, Light A, Biswas A, Hayes
E, Lee HJ, Barad D, Gleicher N and Hammes SR: Androgens regulate
ovarian follicular development by increasing follicle stimulating
hormone receptor and microRNA-125b expression. Proc Natl Acad Sci
USA. 111:3008–3013. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Prizant H, Gleicher N and Sen A: Androgen
actions in the ovary: Balance is key. J Endocrinol. 222:R141–R151.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shi XL, Zhao C, Yang S, Hu XY and Liu SM:
Moxibustion reduces ovarian granulosa cell apoptosis associated
with perimenopause in a natural aging rat model. Evid Based
Complement Alternat Med. 2015(742914)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang CR, Deng JL, Zhu WN, Miao MX, Shen
WW, Cao SJ and Tang Y: Involvement of PI 3 K/Akt/mTOR signaling in
protective effects of moxibustion for premature ovarian failure in
rats. Zhen Ci Yan Jiu. 43:75–79. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
10
|
Wu S and Yan J: Clinical observation on
premature ovarian failure by warming acupuncture at Zusanli (ST 36)
and Guanyuan (CV 4) combined with ginger moxibustion at Baliao
points. Zhongguo Zhen Jiu. 38:1267–1271. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
11
|
Zhu S, Wang Y, Chang X, Chen H and Jin X:
The protective effect of pre-moxibustion on reproductive hormones
profile of rats with tripterygium glycosides-induced ovarian
damage. Complement Med Res. 27:401–409. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shen J, Shen M, Li Z, Zhang R, Li X and Ai
B: Effects of moxibustion at Shenshu (BL 23) on level of sex
hormones and AMH in sub-health peri-menopausal women. Zhongguo Zhen
Jiu. 37:381–385. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
13
|
Yang X, Wang W, Zhang Y, Wang J and Huang
F: Moxibustion improves ovary function by suppressing apoptosis
events and upregulating antioxidant defenses in natural aging
ovary. Life Sci. 229:166–172. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang Y, Yu B, Chen J, Zhao Z, Wang Jiali,
Huang F, Lin Y, Wang M, Zhang Y and Wei B: Effects of acupuncture
on PI3K/Akt/mTOR signaling pathway in rats with premature ovarian
failure. Zhongguo Zhen Jiu. 35:53–58. 2015.PubMed/NCBI(In Chinese).
|
|
15
|
Xia L and Xia Y: Clinical research and the
effect mechanism on premature ovarian failure treated with
acupuncture in recent 20 years. Zhongguo Zhen Jiu. 38:5653–5670.
2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
16
|
Zhou XL, Xu JJ, Ni YH, Chen XC, Zhang HX,
Zhang XM, Liu WJ, Luo LL and Fu YC: SIRT1 activator (SRT1720)
improves the follicle reserve and prolongs the ovarian lifespan of
diet-induced obesity in female mice via activating SIRT1 and
suppressing mTOR signaling. J Ovarian Res. 7(97)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ma M, Chen XY, Gu C, Xiao XR, Guo T and Li
B: Biochemical changes of oxidative stress in premature ovarian
insufficiency induced by tripterygium glycosides. Int J Clin Exp
Pathol. 7:8855–8861. 2014.PubMed/NCBI
|
|
18
|
Zhang T, Yan D, Yang Y, Ma A, Li L, Wang
Z, Pan Q and Sun Z: The comparison of animal models for premature
ovarian failure established by several different source of
inducers. Regul Toxicol Pharmacol. 81:223–232. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guo Y and Fang JQ: Experimental
acupuncture. Beijing: China Traditional Medicine Press, pp402-407,
2012.
|
|
20
|
Machholz E, Mulder G, Ruiz C, Corning BF
and Pritchett-Corning KR: Manual restraint and common compound
administration routes in mice and rats. J Vis Exp.
(2771)2012.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Buerge T and Weiss T: The laboratory
mouse: Handling and restraint. Elsevier, pp517-526, 2004.
|
|
22
|
Morton DB and Griffiths PH: Guidelines on
the recognition of pain, distress and discomfort in experimental
animals and an hypothesis for assessment. Vet Rec. 116:431–436.
1985.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang Q, Lu G, Xie Z, Xie ZJ, Li HX and
Shen MH: Effect of moxibustion on Nrf2/HO-1 signaling pathway in
rats with diminished ovarian reserve. Zhongguo Zhen Jiu. 41:53–58.
2021.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
25
|
Li X and Xu CJ: Diseases of the female
reproductive system 1nd edition. Beijing: People's Medical
Publishing House, pp1-4, 2015.
|
|
26
|
Galey-Fontaine J, Cédrin-Durnerin I,
Chaïbi R, Massin N and Hugues JN: Age and ovarian reserve are
distinct predictive factors of cycle outcome in low responders.
Reprod Biomed Online. 10:94–99. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shatavi SV, Llanes B and Luborsky JL:
Association of unexplained infertility with gonadotropin and
ovarian antibodies. Am J Reprod Immunol. 56:286–291.
2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cohen J, Chabbert-Buffet N and Darai E:
Diminished ovarian reserve, premature ovarian failure, poor ovarian
responder-a plea for universal definitions. J Assist Reprod Genet.
32:1709–1712. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li HF and Tan Y: Discussion on the
prevention and treatment of ovarian reserve function decline from
the idea of treating pre-disease. J Tradit Chin Med. 31:155–157.
2016.
|
|
30
|
Huang XC, Cao XC and Wang XY: Evaluation
and revision of TCM guidelines on premature ovarian failure. Henan
Tradit Chin Med. 39:82–86. 2019.
|
|
31
|
Liao HH, Zhao Y and Shi Y: ZHANG Yu-zhen's
ideas and approaches concerning treatment of premature ovarian
failure. Glob Tradit Chin Med. 8:780–782. 2015.
|
|
32
|
Meng JC and Wang XH: Internal classic.
Plain questions 1nd edition. Shanghai: Shanghai Science and
Technology Press, pp12-20, 2019.
|
|
33
|
Xu H, Zeng L, Yang R, Feng Y, Li R and
Qiao J: Retrospective cohort study: AMH is the best ovarian reserve
markers in predicting ovarian response but has unfavorable value in
predicting clinical pregnancy in GnRH antagonist protocol. Arch
Gynecol Obstet. 295:763–770. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zebitay AG, Cetin O, Verit FF, Keskin S,
Sakar MN, Karahuseyinoglu S, Ilhan G and Sahmay S: The role of
ovarian reserve markers in prediction of clinical pregnancy. J
Obstet Gynaecol. 37:492–497. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Du EQ, Gao X and Shang L: Assessments of
anti-mullerian hormone combining with FSH and FSH/LH in the
advanced maternal women during the reproductive year with ovarian
reserve. Med J West China. 30:701–703. 2018.
|
|
36
|
Zhang H, Luo Q, Lu X, Yin N, Zhou D, Zhang
L, Zhao W, Wang D, Du P, Hou Y, et al: Effects of hPMSCs on
granulosa cell apoptosis and AMH expression and their role in the
restoration of ovary function in premature ovarian failure mice.
Stem Cell Res Ther. 9(20)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lunding SA, Aksglaede L, Anderson RA, Main
KM, Juul A, Hagen CP and Pedersen AT: AMH as predictor of premature
ovarian insufficiency: A longitudinal study of 120 turner syndrome
patients. J Clin Endocrinol Metab. 100:E1030–E1038. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Song JM: Women testosterone levels and
ovarian reserve evaluation index and the correlation of IVF outcome
studies. Kunming: Kunming Medical University, pp26-27, 2016.
|
|
39
|
Walters KA and Handelsman DJ: Role of
androgens in the ovary. Mol Cell Endocrinol. 465:36–47.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gleicher N, Weghofer A, Lee IH and Barad
DH: FMR1 genotype with autoimmunity-associated polycystic
ovary-like phenotype and decreased pregnancy chance. PLoS One.
5(e15303)2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Qin JC, Fan L and Qin AP: The effect of
dehydroepiandrosterone (DHEA) supplementation on women with
diminished ovarian reserve (DOR) in IVF cycle: Evidence from a
meta-analysis. J Gynecol Obstet Hum Reprod. 46:1–7. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Burger HG: Androgen production in women.
Fertil Steril. 77 (Suppl 4):S3–S5. 2002.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Labrie F and Labrie C: DHEA and
intracrinology at menopause, a positive choice for evolution of the
human species. Climacteric. 16:205–213. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gleicher N and Barad DH:
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian
reserve (DOR). Reprod Biol Endocrinol. 9(67)2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Walters KA, Allan CM, Jimenez M, Lim PR,
Davey RA, Zajac JD, Illingworth P and Handelsman DJ: Female mice
haploinsufficient for an inactivated androgen receptor (AR) exhibit
age-dependent defects that resemble the AR null phenotype of
dysfunctional late follicle development, ovulation, and fertility.
Endocrinology. 148:3674–3684. 2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Walters KA, Middleton LJ, Joseph SR, Hazra
R, Jimenez M, Simanainen U, Allan CM and Handelsman DJ: Targeted
loss of androgen receptor signaling in murine granulosa cells of
preantral and antral follicles causes female subfertility. Biol
Reprod. 87(151)2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhu B: The plasticity of acupoint.
Zhongguo Zhen Jiu. 35:1203–1208. 2015.PubMed/NCBI(In Chinese).
|
|
48
|
Xu B and Han X: Discussion on primordial
and sensitized states of acupuncture points. Zhen Ci Yan Jiu.
43:273–276. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
49
|
Zhu H, Nan S, Suo C, Zhang Q, Hu M, Chen
R, Wan J, Li M, Chen J and Ding M: Electro-acupuncture affects the
activity of the hypothalamic-pituitary-ovary axis in female rats.
Front Physiol. 10(466)2019.PubMed/NCBI View Article : Google Scholar
|
